Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells
International Journal of Molecular Sciences · 17.04.2023 · 24 (8) · 7390
DOI: 10.3390/ijms24087390 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.04.2023. Verfasst von Hwan Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea. Hauptthemen laut MEDLINE: NF-kappa B, Neuroprotective Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the "Cooperative Research Program for Agriculture Science & Technology Development" (Project No. PJ01420801) of the Rural Developme…, Rural Development Administration of the Republic of Korea.
Abstract (Originalsprache)
Compounds derived from Curcuma longa L. (C. longa) have been extensively studied and reported to be effective and safe for the prevention and treatment of various diseases, but most research has been focused on curcuminoids derived from C. longa. As neurodegenerative diseases are associated with oxidation and inflammation, the present study aimed to isolate and identify active compounds other than curcuminoids from C. longa to develop substances to treat these diseases. Seventeen known compounds, including curcuminoids, were chromatographically isolated from the methanol extracts of C. longa, and their chemical structures were identified using 1D and 2D NMR spectroscopy. Among the isolated compounds, intermedin B exhibited the best antioxidant effect in the hippocampus and anti-inflammatory effect in microglia. Furthermore, intermedin B was confirmed to inhibit the nuclear translocation of NF-κB p-65 and IκBα, exerting anti-inflammatory effects and inhibiting the generation of reactive oxygen species, exerting neuroprotective effects. These results highlight the research value of active components other than curcuminoids in C. longa-derived compounds and suggest that intermedin B may be a promising candidate for the prevention of neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.
- Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration (RDA), Eumseong 27709, Republic of Korea.
- College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.
- College of Pharmacy, Yanbian University, Yanji 133002, China.
ORCID-Profile: Hwan Lee, Dae Young Lee, Dahye Yoon, Dong-Sung Lee
Förderung
- This research was funded by the "Cooperative Research Program for Agriculture Science & Technology Development" (Project No. PJ01420801) of the Rural Developme…
- Rural Development Administration of the Republic of Korea
Zitieren
APA
Lee, H., Liu, Z., Dong, L., Lee, D. Y., Yoon, D., Oh, H., Kim, Y. C., An, R. B., & Lee, D. S. (2023). Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells. International Journal of Molecular Sciences, 24(8), 7390. https://doi.org/10.3390/ijms24087390
Vancouver
Lee H, Liu Z, Dong L, Lee DY, Yoon D, Oh H, et al. Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells. International Journal of Molecular Sciences. 2023;24(8):7390. doi:10.3390/ijms24087390
BibTeX
@article{Lee2023,
author = {Lee, Hwan and Liu, Zhiming and Dong, Linsha and Lee, Dae Young and Yoon, Dahye and Oh, Hyuncheol and Kim, Youn-Chul and An, Ren-Bo and Lee, Dong-Sung},
title = {Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7390},
doi = {10.3390/ijms24087390}
}
EUVIMED